home / stock / sgmo / sgmo quote
Last: | $0.6247 |
---|---|
Change Percent: | -0.38% |
Open: | $0.6057 |
Close: | $0.6247 |
High: | $0.6444 |
Low: | $0.591 |
Volume: | 2,647,923 |
Last Trade Date Time: | 03/27/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.6247 | $0.6057 | $0.6247 | $0.6444 | $0.591 | 2,647,923 | 03-27-2024 |
$0.6034 | $0.6612 | $0.6034 | $0.6699 | $0.591 | 2,282,595 | 03-26-2024 |
$0.6417 | $0.73 | $0.6417 | $0.75 | $0.6417 | 2,855,904 | 03-25-2024 |
$0.703 | $0.92 | $0.703 | $0.925 | $0.7 | 6,598,653 | 03-22-2024 |
$0.9703 | $0.84 | $0.9703 | $0.9782 | $0.8398 | 2,557,942 | 03-21-2024 |
$0.8161 | $0.7882 | $0.8161 | $0.8275 | $0.76 | 1,075,021 | 03-20-2024 |
$0.77 | $0.87 | $0.77 | $0.9198 | $0.7631 | 2,363,074 | 03-19-2024 |
$0.851 | $0.7649 | $0.851 | $0.8662 | $0.76 | 2,089,347 | 03-18-2024 |
$0.78 | $0.8417 | $0.78 | $0.8654 | $0.777 | 3,225,773 | 03-15-2024 |
$0.78 | $0.84 | $0.78 | $0.92 | $0.7763 | 2,373,888 | 03-14-2024 |
$0.7851 | $0.88 | $0.7851 | $0.92 | $0.777 | 2,866,521 | 03-13-2024 |
$0.8611 | $0.85 | $0.8611 | $0.8822 | $0.84 | 1,188,607 | 03-12-2024 |
$0.8824 | $0.91 | $0.8824 | $0.94 | $0.8608 | 847,726 | 03-11-2024 |
$0.9061 | $0.9193 | $0.9061 | $0.99 | $0.878 | 1,391,209 | 03-08-2024 |
$0.9193 | $1.04 | $0.9193 | $1.04 | $0.8951 | 2,220,836 | 03-07-2024 |
$1.01 | $1.05 | $1.01 | $1.05 | $0.98 | 1,351,802 | 03-06-2024 |
$1.03 | $0.9896 | $1.03 | $1.04 | $0.97 | 1,423,077 | 03-05-2024 |
$1.02 | $1.11 | $1.02 | $1.12 | $0.99 | 2,511,817 | 03-04-2024 |
$1.11 | $1.15 | $1.11 | $1.17 | $1.06 | 1,670,666 | 03-01-2024 |
$1.16 | $1.11 | $1.16 | $1.19 | $1.08 | 2,435,481 | 02-29-2024 |
News, Short Squeeze, Breakout and More Instantly...
Sangamo Therapeutics Inc. Company Name:
SGMO Stock Symbol:
NASDAQ Market:
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that it has entered into a securities purchase agreement with institutional investors, providing for the purchase and sale of an aggregate of 24,761,905 shares of its common stock and pre-funded warrants to pur...
H.C. Wainwright initiated coverage on Voyager Therapeutics Inc (NASDAQ:VYGR), noting a growing franchise of novel, highly-differenti...
2024-03-13 15:30:02 ET H.C. Wainwright analyst issues BUY recommendation for SGMO on March 13, 2024 02:00PM ET. The previous analyst recommendation was Buy. SGMO was trading at $0.801 at issue of the analyst recommendation. The overall analyst consensus : BUY. Curren...